Abstract:To improve transporting drugs across the Blood Brain Barrier (BBB) into the brain, RMP-7 was conjugated to the surface of liposomes containing Amphotericin B (AmB) for cerebral inflammation, because it can selectively bound to the B2 receptors on the capillary blood vessel. First, RMP-7 was conjugated to DSPE-PEG-NHS [1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n-[poly (ethylenegly-col)]-hydroxy succinamide, PEG M 3400] under mild condition to obtain a predominantly 1:1 conjugate (DSPE-PEG-RMP-7), as evidenced by the Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS). The second, endothelium cell was cultured on the cell insert to form an in vitro BBB model and the stereoscan microscope, electric resistance and permeation of horse-radish peroxidase (HRP) across the endothelium cell monolayer were used as indicators to evaluate the integrality of the monolayer, and then the in vitro BBB model was used to determine the bioactivity of DSPE-PEG-RMP-7 "opening" BBB. The results demonstrated the in vitro BBB model was set up, RMP-7 and DSPE-PEG-RMP-7 could improve the transporting of HRP across the BBB. The third, the liposomes containing AmB (AmB-L-PEG) was prepared by modified Film-sonication method and DSPE-PEG-RMP-7 was used to modify the AmB-L-PEG to obtain AmB-L-PEG-RMP-7. The fourth, tissue distribution of AmB in the rats of three groups was determined: Group I, AmB-L-PEG; Group II, AmB-L-PEG+RMP-7 (the physical mixture of AmB-L-PEG and RMP-7); Group III, AmB-PEG-RMP-7. The drugs were transfused into the rats through the femoral vein. The concentration of AmB in the tissue was checked using High-Performance Liquid Chromatography (HPLC) method. The rank of AmB concentration in the brain were as follows: III>II>I. The AmB concentration in the liver, spleen, lung and kidney had no significant difference. The concentration of AmB in the brain of the group III was raised several times higher than that in the other two groups, because the DSPE-PEG-RMP-7 had been inserted in the surface of AmB-L-PEG. Both the RMP-7 and AmB-L-PEG could reach BBB at the same time. When RMP-7 selectively reacted with the B2 receptor, the BBB is "opened" and AmB was transported into the brain at the same time. While in group II, the RMP-7 could improve the AmB concentration in the brain a little, because the RMP-7 and liposomes could not reach BBB at the same time. The distribution of AmB in the tissues demonstrated that the RMP-7 and its derivative had selectivity to the brain.

Body Distributioin of RGD-mediated Liposome in Brain-Targeting Drug Delivery.

Surface Modification of RGD-liposomes for Selective Drug Delivery to Monocytes/neutrophils in Brain.

The study on brain targeting of the amphotericin B liposomes

Brain-targeted Drug Delivery by in Vivo Functionalized Liposome with Stable D-peptide Ligand.

Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.

A Novel Lactoferrin-Modified Β-Cyclodextrin Nanocarrier for Brain-Targeting Drug Delivery.

Lactoferrin-conjugated PEG–PLA Nanoparticles with Improved Brain Delivery: in Vitro and in Vivo Evaluations

Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression

In Vitro and in Vivo Investigation of Glucose-Mediated Brain-Targeting Liposomes.

Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency

Peptide-22 and Cyclic Rgd Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming Bbb and Bbtb

Preparation, Characterization, and Evaluation of Liposomal Ferulic Acid in Vitro and in Vivo

A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinsons disease

Brain-Targeting Mechanisms of Lactoferrin-Modified DNA-Loaded Nanoparticles

Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain Delivery

Liposome Formulated with TAT-modified Cholesterol for Improving Brain Delivery and Therapeutic Efficacy on Brain Glioma in Animals

A Dual-Mediated Liposomal Drug Delivery System Targeting the Brain: Rational Construction, Integrity Evaluation Across the Blood-Brain Barrier, and the Transporting Mechanism to Glioma Cells

Brain targeting of Baicalin and Salvianolic acid B combination by OX26 functionalized nanostructured lipid carriers

Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection

Effect of Lactoferrin- and Transferrin-Conjugated Polymersomes in Brain Targeting: in Vitro and in Vivo Evaluations